Skip to content

Clinical trials

Phase 3 Narcolepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 3 Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20046
20052
20092
20101
20111
20121
20131
20141
20152
20162
20171
20201
20212
20241
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bioprojet7
Cephalon7
Jazz Pharmaceuticals7
Avadel2
Axsome Therapeutics, Inc.2
Alkermes, Inc.1
Harmony Biosciences Management, Inc.1
NLS Pharmaceutics1
Orphan Medical1
Suven Life Sciences Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy31
Disorders of Excessive Somnolence18
Cataplexy17
Sleep Apnea, Obstructive5
Sleep Wake Disorders5
Fatigue2
Chronobiology Disorders1
Idiopathic Hypersomnia1
Parasomnias1
Sleep Apnea Syndromes1

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.